Statistical explanations for a community-based study of once-weekly epoetin alfa therapy in patients receiving chemotherapy

被引：2
|
作者：
Gabrilove, JL [1 ]
Sarokhan, B
Cremieux, P
机构：
[1] CUNY, Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Ortho Biotech Prod, LP, Raritan, NJ USA
[3] Anal Grp Econ, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 11期
关键词：
D O I：
10.1200/JCO.2002.20.11.2757
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2757 / 2758
页数：2
相关论文
共 50 条
  • [31] Once-weekly epoetin beta therapy in patients with solid tumours and chemotherapy-induced anaemia: a randomized, double-blind, dose-finding study
    Heras, P.
    Kritikos, K.
    Hatzopoulos, A.
    Mitsibounas, D.
    EUROPEAN JOURNAL OF CANCER CARE, 2008, 17 (06) : 619 - 623
  • [32] A comparison between once-weekly and twice- or thrice-weekly subcutaneous injection of epoetin alfa: results from a randomized controlled multicentre study
    Lee, Young Ki
    Kim, Sung Gyun
    Seo, Jang Won
    Oh, Ji Eun
    Yoon, Jong-Woo
    Koo, Ja-Ryong
    Kim, Hyung Jik
    Noh, Jung Woo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (10) : 3240 - 3246
  • [33] Epoetinα 40K (40,000 IU) once-weekly improves hemoglobin levels and quality of life in anemic cancer patients receiving chemotherapy
    Carteni, Giacomo
    Giannetta, Laura
    Ciotti, Renato
    De Signoribus, Giorgio
    Vecchione, Aldo
    Pinotti, Graziella
    Puglisi, Fabio
    Contillo, Antonio
    Pezzella, Giuseppe
    Orecchia, Simona
    ANNALS OF ONCOLOGY, 2005, 16 : 76 - 76
  • [34] Utilization trends of epoetin alfa and darbepoetin alfa in adult patients with cancer receiving chemotherapy in community practice settings.
    Coletti, T
    Howell, JB
    Todoroff, K
    Gregory, KL
    Fastenau, JM
    BLOOD, 2004, 104 (11) : 413B - 413B
  • [35] Cognitive effects of once weekly (QW) epoetin alfa in anemic patients (pts) with hematologic malignancies receiving chemotherapy (CT): Interim results of the EPOLYM trial.
    Gisselbrecht, C
    Tesch, H
    Jourdan, E
    Avvisati, G
    Tsatalas, C
    Marschner, N
    BLOOD, 2004, 104 (11) : 609A - 609A
  • [36] Effectiveness and safety of an induction therapy with epoetin alfa in anemic cancer patients receiving concomitant chemotherapy
    Cortesi, E
    Mancuso, A
    Ceratti, AD
    Pizzardi, N
    D'Auria, G
    Accettura, C
    Beccaglia, P
    Bertelletti, D
    De Marinis, F
    ONCOLOGIST, 2004, 9 (04): : 459 - 468
  • [37] Comparing the efficacy of two fixed dose of epoetin alfa, 40,000 iu once-weekly (QW) versus 10,000 iu three-times-weekly (TIW), in anemic cancer patients receiving chemotherapy (CT)
    Munoz-Langa, Jose
    Juan, Oscar
    Almenar, Daniel
    Alberola, Vicente
    Olmos, Santiago
    Albert, Ana
    Molins, Carmen
    Campos, Juan M.
    Bosch, Carlos
    Caranana, Vicente
    ANNALS OF ONCOLOGY, 2006, 17 : 295 - 296
  • [38] A Randomized Controlled Study Comparing Once-Weekly to Every-2-Week and Every-4-Week Dosing of Epoetin Alfa in CKD Patients with Anemia
    Pergola, Pablo E.
    Gartenberg, Gary
    Fu, Min
    Sun, Steven
    Wofson, Marsha
    Bowers, Peter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04): : 598 - 606
  • [39] Weekly epoetin alfa maintains hemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy
    Chang, J
    Couture, F
    Young, S
    McWatters, KL
    Lau, CY
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2597 - 2605
  • [40] Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: A retrospective subanalysis of two large, community-based trials
    Glaspy, J
    Degos, L
    Dicato, M
    Demetri, GD
    ONCOLOGIST, 2002, 7 (02): : 126 - 135
12345